MKS Inc. (MKSI) Stock Analysis
Range Bound setup
Technology · Scientific & Technical Instruments
Sell if holding. At $270.07, A.R:R is negative (-0.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: international revenues (81.0%); Concentration risk — Supplier: sole and limited source suppliers.
MKS Inc. designs and manufactures instruments, subsystems, and specialty chemicals for semiconductor, electronics/packaging, and specialty industrial markets through three divisions (VSD, PSD, MSD). Revenue is derived from global equipment and consumables sales; ~81% from... Read more
Sell if holding. At $270.07, A.R:R is negative (-0.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: international revenues (81.0%); Concentration risk — Supplier: sole and limited source suppliers. Chart setup: RSI 51 mid-range, Bollinger mid-band. Score 4.9/10, high confidence.
Passes 4/7 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 6d<=7d. Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHGeographicinternational revenues81%10-K Item 1A: 'For 2025, 2024, and 2023, international net revenues accounted for approximately 81%, 78%, and 75%, respectively, of our total net revenues.'
- MEDIUMProductsemiconductor market43%10-K Item 1A: 'Approximately 43%, 42%, and 41% of our net revenues for 2025, 2024, and 2023, respectively, were from sales to our semiconductor market.'
- HIGHSuppliersole and limited source suppliers10-K Item 1A: 'Our dependence on sole and limited source suppliers and international suppliers has negatively impacted, and could continue to impact, our ability to manufacture products'
Material Events(8-K, last 90d)
- 2026-04-06Item 5.02MEDIUMEVP General Counsel Kathleen Burke notified intent to retire effective June 1, 2026; remaining as special advisor through July 1. No successor named at time of filing.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $270.07, A.R:R is negative (-0.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: international revenues (81.0%); Concentration risk — Supplier: sole and limited source suppliers. Chart setup: RSI 51 mid-range, Bollinger mid-band. Prior stop was $251.01. Score 4.9/10, high confidence.
Take-profit target: $288.17 (+6.8% upside). Prior stop was $251.01. Stop-loss: $251.01.
Concentration risk — Geographic: international revenues (81.0%); Concentration risk — Supplier: sole and limited source suppliers; Analyst target reached - limited upside remaining.
MKS Inc. trades at a P/E of 60.6 (forward 21.7). TrendMatrix value score: 4.5/10. Verdict: Sell.
20 analysts cover MKSI with a consensus score of 4.0/5. Average price target: $304.
What does MKS Inc. do?MKS Inc. designs and manufactures instruments, subsystems, and specialty chemicals for semiconductor,...
MKS Inc. designs and manufactures instruments, subsystems, and specialty chemicals for semiconductor, electronics/packaging, and specialty industrial markets through three divisions (VSD, PSD, MSD). Revenue is derived from global equipment and consumables sales; ~81% from international customers in 2025, with the semiconductor market representing ~43% of net revenues.